PIN Pharma Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

PIN Pharma General Information

Description

Developer of precision immune stimulants designed to link innate and adaptive immune systems. The company's stimulants target breast and colon cancer to overcome cancer-mediated immune suppression, enabling physicians to perform treatment in an enhanced way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 55 Broadway
  • Suite 315
  • New York, NY 10006
  • United States
+1 (212)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • 55 Broadway
  • Suite 315
  • New York, NY 10006
  • United States
+1 (212)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PIN Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 01-Apr-2021 Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2012 Completed Startup
To view PIN Pharma’s complete valuation and funding history, request access »

PIN Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view PIN Pharma’s complete cap table history, request access »

PIN Pharma Patents

PIN Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014329393-A1 Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment Active 04-Oct-2013
AU-2014329393-B2 Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment Inactive 04-Oct-2013
CA-2926221-A1 Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment Inactive 04-Oct-2013
EP-3052127-A1 Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment Inactive 04-Oct-2013
WO-2015051245-A1 Immunostimulatory hiv tat derivative polypeptides for use in cancer treatment Inactive 04-Oct-2013 A61K38/162
To view PIN Pharma’s complete patent history, request access »

PIN Pharma FAQs

  • When was PIN Pharma founded?

    PIN Pharma was founded in 2011.

  • Where is PIN Pharma headquartered?

    PIN Pharma is headquartered in New York, NY.

  • What industry is PIN Pharma in?

    PIN Pharma’s primary industry is Drug Discovery.

  • Is PIN Pharma a private or public company?

    PIN Pharma is a Private company.

  • What is PIN Pharma’s current revenue?

    The current revenue for PIN Pharma is .

  • How much funding has PIN Pharma raised over time?

    PIN Pharma has raised $6.75M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process